DPP-4 inhibitors may cause severe joint pain

FDA said that sitagliptin, saxagliptin, linagliptin, and alogliptin may cause joint pain, and their labels have been revised to include this risk. More

FDA

FDA approves Synjardy for T2DM

FDA has approved empagliflozin and metformin hydrochloride tablets for treating adults with type 2 diabetes. More

EDITOR'S CHOICE

Progress made on drug shortages although manufacturing issues persist

While the rate of new drug shortages has fallen, manufacturing problems and import bans continue to cause shortages of certain medications. More

Inside The Latest Issue

Safeguarding the U.S. supply chain "Pharmacists are the drug experts. Call us first!" Nine tips on how to manage like a boss

September 03, 2015

Continuing education

Primer on Inhalers and nebulizers: August 2015 CPE

MTM essentials for COPD management: Part 2

MTM essentials for COPD management: Part 1

Get the free app!

UBM MEDICA